Trial Information
An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus (HPV) Types in Women >= 18 Years of Age, in Egypt
Inclusion Criteria:
- Women >= 18 years of age attending a clinic for gynaecological examination.
- Women who agree to provide a cervical sample for human papillomavirus testing.
- Written informed consent obtained from the subject.
Exclusion Criteria:
- Referral for abnormal cervical sample at the current visit.
- Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening
to be performed.
- History of hysterectomy.
- Known diagnosis of immunosuppression, or patient on immunosuppressives.
- Pregnant women.
- Having received one or more doses of HPV vaccine prior to participating in the study.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Occurrence of Human papillomavirus (HPV) DNA and of any of the HPV types among women undergoing cervical sample testing.
Outcome Time Frame:
Average timeframe: 12 months
Safety Issue:
No
Principal Investigator
GSK Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
GlaxoSmithKline
Authority:
Egypt: Ministry of Health
Study ID:
113367
NCT ID:
NCT01158209
Start Date:
October 2010
Completion Date:
August 2011
Related Keywords:
- Human Papillomavirus Infection
- Warts
- Papillomavirus Infections